Literature DB >> 1174958

Muscle receptors with group IV afferent fibres responding to application of bradykinin.

M Franz, S Mense.   

Abstract

In 60 anaesthetized cats the discharge characteristics of single group IV afferent fibres from skeletal muscle at rest, during local mechanical stimulation of the muscle, and in response to injections of bradykinin have been studied. 250 group IV fibres from the gastrocnemius-soleus muscle have been identified by their conduction velocity. Of these fibres 121 have been recorded from the dorsal root and 129 from the muscle nerve. A resting discharge was present in 52% of the dorsal root fibres and in 57% of the fibres recorded peripherally. Out of 203 units subjected to local mechanical stimulation of the muscle 9 responded to light, innocuous pressure; 129 fibres required strong, presumably noxious stimulation to be excited. The rest of 65 fibres could not be activated by the mechanical stimuli used. Intraarterial injection of bradykinin excited 88 out of 184 group IV fibres. Intramuscular injection of bradykinin was also found to be an effective stimulus. External application of bradykinin to the intact and to the dissected muscle nerve regularly had no excitatory effect on fibres being sensitive to intraarterially administered bradykinin. Injections of vasoactive drugs (nylidrine, noradrenaline) failed to affect the activity of group IV fibres responding to bradykinin. It is concluded that bradykinin is a potent stimulant for the intramuscular endings of afferent group IV fibres; the effective concentration lying within the range observed in pathologically altered tissues. This sensitivity to bradykinin together with a high mechanical threshold suggests that muscular group IV afferent units participate in the reception of muscular pain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174958     DOI: 10.1016/0006-8993(75)90323-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  27 in total

1.  Changes in discharge rate of fusimotor neurones provoked by fatiguing contractions of cat triceps surae muscles.

Authors:  M Ljubisavljević; K Jovanović; R Anastasijević
Journal:  J Physiol       Date:  1992-01       Impact factor: 5.182

2.  Nervous outflow from skeletal muscle following chemical noxious stimulation.

Authors:  S Mense
Journal:  J Physiol       Date:  1977-05       Impact factor: 5.182

3.  The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat.

Authors:  B D Grubb; G J Birrell; D S McQueen; A Iggo
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

4.  Evidence for the existence of different receptor sites for algesic agents at the endings of muscular group IV afferent units.

Authors:  E Hiss; S Mense
Journal:  Pflugers Arch       Date:  1976-03-30       Impact factor: 3.657

5.  Response of chemosensitive nerve fibers of group III and IV to metabolic changes in rat muscles.

Authors:  F Thimm; K Baum
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

6.  Dependence of histamine-evoked nociception on prostaglandin release.

Authors:  H Juan
Journal:  Agents Actions       Date:  1981-12

7.  Responses of group IV afferent units from skeletal muscle to stretch, contraction and chemical stimulation.

Authors:  K D Kniffki; S Mense; R F Schmidt
Journal:  Exp Brain Res       Date:  1978-04-14       Impact factor: 1.972

8.  Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro.

Authors:  A Dray; I A Patel; M N Perkins; A Rueff
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

9.  The effects of bradykinin and prostaglandin E1 on rat cutaneous afferent nerve activity.

Authors:  L A Chahl; A Iggo
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

10.  Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.

Authors:  C R Corrêa; J B Calixto
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.